Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
296.49
+6.49 (2.24%)
Jun 24, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.33 billion as of June 24, 2026. Its market cap has increased by 19.42% in one year.
Market Cap
7.33B
Enterprise Value
7.15B
1-Year Change
19.42%
Ranking
Category
Stock Price
$296.49
Market Cap Chart
Since June 25, 2021, Bio-Rad Laboratories's market cap has decreased from $18.86B to $7.33B, a decrease of -61.11%. That is a compound annual growth rate of -17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 7.55B | -7.57% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 19.93% |
| Jun 25, 2021 | 18.86B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 17.37B |
| Smith & Nephew | 12.52B |
| Penumbra | 12.52B |
| Globus Medical | 11.25B |
| Insulet | 10.25B |
| Bruker | 8.82B |
| Glaukos | 8.18B |
| Bio-Rad Laboratories | 7.51B |